Quick Summary

Honeysuckle (Lonicera japonica) is a traditional Chinese medicinal herb with a long history of use, especially in respiratory and inflammatory conditions. Its bioactive components, such as chlorogenic acid and related polyphenols, have been studied for potential multi-target effects including anti-inflammatory, antiviral, antioxidant, and immunomodulatory actions. Most clinical evidence comes from randomized controlled trials in China, often using multi-herbal formulas or traditional injections. Some promising benefits have been observed in respiratory infections, community-acquired pneumonia, inflammatory states, and diabetes management. However, the overall certainty of the evidence is limited due to methodological issues. Safety data indicate a generally favorable profile with mostly mild adverse effects reported. Comprehensive information on herb-drug interactions and contraindications is still lacking.

What is it?

Honeysuckle (Lonicera japonica) is a flowering vine native to East Asia, widely used in traditional Chinese medicine (TCM). It is commonly utilized in various forms including decoctions, extracts, and injectable preparations. The plant contains several bioactive compounds believed to contribute to its therapeutic properties.

Traditional Uses

  • Treatment of respiratory tract infections and inflammation
  • Alleviation of symptoms related to pneumonia and influenza
  • Management of inflammatory and immune-related conditions
  • Support in diabetic wound healing
  • Use as part of multi-herbal formulations to promote overall health and immune modulation

Active Compounds

The primary active compounds include chlorogenic acid and related polyphenols. These constituents are thought to contribute to anti-inflammatory, antiviral, antioxidant, and immunomodulatory effects. Other phytochemicals may also be involved, but chlorogenic acid is among the most studied.

Potential Benefits with Evidence Levels

  • Adjunct treatment in community-acquired pneumonia and respiratory infections (Moderate to low certainty)
    Evidence from meta-analyses and randomized controlled trials (RCTs) suggests that TCM injections and oral liquids containing Lonicera japonica may improve clinical outcomes and symptom resolution in pneumonia and pediatric influenza.
    Sources: Yang H et al. 2025; Guo S et al. 2025; Ling Y et al. 2025; Huang X et al. 2024
  • Anti-inflammatory and immune modulation effects (Preclinical and preliminary clinical data)
    Systematic reviews and RCTs indicate bioactive components may inhibit inflammatory mediators (e.g., TNF-α, IL-6) and regulate immune pathways relevant to respiratory and inflammatory diseases.
    Sources: Cao YF et al. 2025; Lin S et al. 2024; Cui R et al. 2025
  • Support in metabolic and diabetic conditions (Systematic reviews with moderate certainty)
    Formulations containing Lonicera japonica show potential to improve glycemic control, lipid profiles, insulin resistance in type 2 diabetes, and enhance healing in diabetic foot ulcers.
    Sources: Tang S et al. 2025; Yan X et al. 2026
  • Adjunct therapy in inflammatory lung injury and ventilator-associated pneumonia (Low to moderate certainty)
    Preparations such as Tanreqing injection may reduce inflammation markers, mechanical ventilation duration, ICU stay, and improve clinical pulmonary infection scores.
    Sources: Li P et al. 2025; Chen J et al. 2025
  • Antiviral activity against respiratory viruses including SARS-CoV-2 (Preclinical and early clinical trials, low to moderate certainty)
    In vitro and clinical reviews suggest antiviral and immunomodulatory properties that may suppress viral entry and cytokine storm pathways.
    Sources: Multiple sources including systematic reviews 2020–2022; Hu S et al. 2023

Side Effects

Honeysuckle and its preparations generally have a favorable safety profile. Most studies report mild or no serious adverse events. Mild adverse reactions have occasionally been observed, particularly with injection formulations, but adverse event rates are low and not significantly different from controls.

Drug Interactions

Current evidence on herb-drug interactions with Lonicera japonica is limited. Because it is frequently used within multi-herbal formulas and combined with antibiotics or antivirals, further systematic investigation is needed to clarify potential interactions.

Who Should Avoid It

  • Individuals with severe comorbidities should exercise caution, especially when considering intravenous formulations.
  • Pregnant and breastfeeding women should avoid use or consult healthcare professionals due to insufficient safety data.
  • People taking multiple medications or undergoing complex treatment regimens should seek medical advice before use.

Evidence Limitations

  • Majority of clinical trials originate from China, which may limit generalizability due to regional bias.
  • Many studies suffer from methodological limitations such as small sample sizes, lack of blinding, and incomplete data reporting.
  • Heterogeneity in herbal preparation types and combined therapies complicates attribution of specific effects to Lonicera japonica.
  • Long-term safety data and pharmacokinetic studies are sparse.
  • High-quality randomized controlled trials are needed to confirm efficacy and optimal dosing.
  • Robust data on herb-drug interactions and contraindications remains lacking.

References

  • Yang H, Wang J, Zhang K, Xie K, Ji W, Wang H. Efficacy and safety of traditional Chinese medicine injections for older adults with community-acquired pneumonia: An evidence map. 2025; PMC12746979. doi.org/10.1097/md.0000000000046849
  • Guo S et al. Efficacy and safety of Xiao’er Fengre Qing oral liquid versus Oseltamivir in treating pediatric influenza: a multicenter, randomized, non-inferiority trial. 2025; PMC12137347. doi.org/10.3389/fphar.2025.1584003
  • Ling Y et al. Effectiveness and safety of Maxing Shigan Decoction for community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials. 2025; PMC12425732. doi.org/10.3389/fmed.2025.1639027
  • Huang X et al. The efficacy of azithromycin combined with seven types of Chinese medicine injections in the treatment of Mycoplasma pneumoniae pneumonia in children: a systematic review and Bayesian network meta-analysis. 2024; PMC11484089. doi.org/10.3389/fphar.2024.1378445
  • Cao YF et al. Lonicera japonica Thunb. in acute lung injury: A systematic review of bioactive components and multi-target mechanisms. 2025. doi.org/10.1016/j.fitote.2025.106764
  • Lin S et al. Exploring the mechanism of Lianhuaqingwen (LHQW) in treating chronic bronchitis based on network pharmacology and experimental validation. 2024; PMC11295316. doi.org/10.1186/s12931-024-02927-7
  • Cui R et al. Immunomodulatory effects and mechanisms of Qi-Xu-Tiao-Ti formula in Qi-deficiency constitution: a randomized controlled trial integrated with multi-omics and network pharmacology analysis. 2025; PMC12615400. doi.org/10.3389/fimmu.2025.1675502
  • Tang S et al. Evaluating efficacy and mechanism of traditional Chinese medicine in diabetes treatment: a meta-analysis and network pharmacology study. 2025; PMC12537397. doi.org/10.3389/fendo.2025.1605091
  • Yan X et al. Efficacy and safety of external phytotherapy in diabetic foot ulcers: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. 2026; PMC12879332. doi.org/10.1186/s13098-025-02049-0
  • Li P et al. Effects of Tanreqing injection against ventilator-associated pneumonia: a meta-analysis and systematic review of clinical studies. 2025; PMC11925857. doi.org/10.3389/fphar.2025.1545088
  • Hu S et al. An updated meta-analysis of Chinese herbal medicine for the prevention of COVID-19 based on Western-Eastern medicine. 2023; PMC10693348. doi.org/10.3389/fphar.2023.1257345
  • Zhao S et al. Chinese herbal compound for multidrug-resistant or extensively drug-resistant bacterial pneumonia: a meta-analysis and trial sequential analysis with association rule mining to identify core herb combinations. 2023; PMC10761442. doi.org/10.3389/fphar.2023.1282538

Last Reviewed

April 2024

Disclaimer: This information is provided for educational purposes and is not intended as medical advice. Honeysuckle (Lonicera japonica) may have potential health effects based on current research, but it should not replace professional medical diagnosis or treatment. Consult a healthcare provider before using herbal products, especially if you are pregnant, breastfeeding, have any health conditions, or are taking other medications.